Industry Focus

Earnings season is in full swing, and in this week’s Industry Focus: Financials, host Jason Moser and Fool.com contributor Matt Frankel, CFP discuss the latest results from PayPal (NASDAQ: PYPL) and Visa (NYSE: V). Also, at the Money 20/20 conference in Las Vegas, Frankel had a chance to sit down with Green Dot’s (NYSE: GDOT) BaaS (Banking as a Service) team for an update on the company’s business and new partnership. Plus, we hear about some more recent stocks our listeners bought, and more on this week’s show.   Check out more of our content here:

• TMF's podcast portal
• YouTube
• Twitter
• Join Our Motley Fool Podcast Facebook Group
• LinkedIn
• StockUp, The Motley Fool's weekly email newsletter

It's been a tumultuous couple of months since we did our S-1 show on co-working start up The We Company (or WeWork). Fellow IF host Nick Sciple hops on to walk through what has happened over the past couple weeks, what We's sliding valuation means for the company, investor Softbank, and its founder Adam Neumann.

Check out more of our content here:

• TMF's podcast portal
• YouTube
• Twitter
• Join Our Motley Fool Podcast Facebook Group
• LinkedIn
• StockUp, The Motley Fool's weekly email newsletter

Get $50 off your first job post. Linkedin.com/fool

Tesla shocked the investing world on Wednesday night, reporting a surprise profit and positive free cash flow in its third quarter earnings report. Motley Fool Analysts Jim Mueller and Jim Gillies join the show to break down the numbers. 

Stocks Mentioned: TSLA

Check out more of our content here:

• TMF's podcast portal
• YouTube
• Twitter
• Join Our Motley Fool Podcast Facebook Group
• LinkedIn
• StockUp, The Motley Fool's weekly email newsletter

Thanks to Molekule for supporting our podcast.   Get 10% off your first air purifier at http://www.molekule.com with code “fool10”.

2019 has been a banner year for big name IPOs, but several newly minted public companies have flow under-the-radar of most investors.  On this episode of Industry Focus: Healthcare, host Shannon Jones talks with healthcare specialist Brian Feroldi shine a spotlight on two little-known healthcare companies that recently went public and deserve some attention: TransMedics, an organ transportation specialist, and Silk Road Medical, which has pioneered a new treatment for stroke prevention. Are either of these stocks worth buying today?   Stocks mentioned: TMDX, SILK.   Check out more of our content here:

• TMF's podcast portal
• YouTube
• Twitter
• Join Our Motley Fool Podcast Facebook Group
• LinkedIn
• StockUp, The Motley Fool's weekly email newsletter

On this week’s episode of Industry Focus: Consumer Goods host Jason Moser and Fool.com contributor Asit Sharma take a closer look at Land's End and Herman Miller, two sleeper stocks with some big potential. Plus Jason and Asit highlight four companies with earnings reports coming out later this week that they'll be following. Thanks to Molekule for supporting Industry Focus.  

Stocks: LE, MLHR, TSCO, AMZN, ORLY, ELY

Check out more of our content here:

• TMF's podcast portal
• YouTube
• Twitter
• Join Our Motley Fool Podcast Facebook Group
• LinkedIn
• StockUp, The Motley Fool's weekly email newsletter

Get 10% off your first air purifier at http://www.molekule.com with code fool10. 

Earnings season is now in full swing, and most major U.S. banks have reported. In today’s Industry Focus: Financials, host Jason Moser and Fool.com contributor Matt Frankel, CFP discuss the results from 10 of the most important banks and what investors need to know. Plus, the pair discusses Schwab’s (NASDAQ: SCHW) decision to allow trading of fractional shares of stock, as well as the potential implications of the WeWork saga.

Check out more of our content here:

• TMF's podcast portal
• YouTube
• Twitter
• Join Our Motley Fool Podcast Facebook Group
• LinkedIn
• StockUp, The Motley Fool's weekly email newsletter

We're back with another deep dive on a software company currently undergoing the transition from the license model to SaaS -- Manhattan Associates. We run the company through contributor Brian Feroldi's checklist.   Stocks: MANH   Check out more of our content here:

• TMF's podcast portal
• YouTube
• Twitter
• Join Our Motley Fool Podcast Facebook Group
• LinkedIn
• StockUp, The Motley Fool's weekly email newsletter

With the cost of solar energy plummeting and an aging energy grid, solar is poised for rapid growth. As solar grows, so will demand for solar components, like the inverters made by Enphase and Solar Edge. On today’s episode, Motley Fool Contributor Jason Hall joins the show to break down why these components are so important and how these businesses are positioning themselves to grow.  

Listen to hear us talk a little college football and baseball playoffs!

Check out more of our content here:

• TMF's podcast portal
• YouTube
• Twitter
• Join Our Motley Fool Podcast Facebook Group
• LinkedIn
• StockUp, The Motley Fool's weekly email newsletter

Pfizer's latest phase 3 trial results put its promising eczema drug on a path to challenge Regeneron and Sanofi's $2 billion-per-year drug, Dupixent. Also, how Regenxbio and Adverum Biotechnologies hope to change how a we treat a common cause of vision loss in seniors, and why United Healthcare's latest quarterly results sent shares soaring.

Check out more of our content here:

• TMF's podcast portal
• YouTube
• Twitter
• Join Our Motley Fool Podcast Facebook Group
• LinkedIn
• StockUp, The Motley Fool's weekly email newsletter

Chanticleer Holdings, the company that owns a handful of Hooters locations along with other eateries in the burger space is being purchased by Sonnet BioTherapeutics Inc., a company that makes cancer drugs. This isn’t a combination or a plan to get researchers to wear short shorts, it’s what’s called a reverse merger. Also, Costco has opened up its own chicken farm in a bid to keep selling rotisserie chickens for $4.99.

Check out more of our content here:

• TMF's podcast portal
• YouTube
• Twitter
• Join Our Motley Fool Podcast Facebook Group
• LinkedIn
• StockUp, The Motley Fool's weekly email newsletter